Introduction
============

International high-risk clones of *Klebsiella* *pneumoniae* are among the most common Gram- negative pathogens. In addition to community-acquired infections, it has been known for decades that due to their ability to spread rapidly in hospital environment, these bacteria can cause several outbreaks. Multi-drug resistant (MDR) *K. pneumoniae* emerged and dramatically increased prevalence of nosocomial infections while *K. oxytoca* has been isolated in hospital infections with less frequency ([@B41]; [@B29]; [@B57]).

Multi-drug resistant *K. pneumoniae* acquires various resistance mechanisms that confer antibiotic resistance to commonly used antibiotics. Among the most frequent resistance mechanisms are extended-spectrum β-lactamases (ESBLs), plasmid-mediated AmpC enzyme (pAmpCs), carbapenemases, plasmid-mediated quinolone resistance (PMQR) genes, aminoglycoside-modifying enzymes (AMEs), as well as exogenously acquired 16S rRNA methyltransferase that have been detected in clinical isolates ([@B53]; [@B31]; [@B9]; [@B6]). Presence of PMQR genes including *qnr* determinants, *aac(6*′*)-Ib-cr, qepA* and *oqxAB* efflux pumps confer reduced susceptibility to fluoroquinolones and facilitate selection of fluoroquinolone resistance in Enterobacterales ([@B45]; [@B10]). High-risk *K. pneumoniae* clones have acquired these antibiotic resistance determinants, that enabled them to increase their pathogenicity and survival skills. These clones have tenacity and flexibility to accumulate resistance determinants and they have contributed to disseminate global multi-drug resistance ([@B51]). Consequently, increased diversity of plasmid-encoded antimicrobial resistance genes facilitates spread of these clones, causing significant therapeutic difficulties.

Multi-drug resistant *K. pneumoniae* strains mainly belong to certain sequence types (ST) namely, ST11, ST14, ST15, ST37, ST101, ST147, ST258, ST336, ST340, and ST874. These represent high-risk international clones that played major role in dissemination in hospital settings and increased frequency in nosocomial infections ([@B13]; [@B26]; [@B5]; [@B36]; [@B44]; [@B23]). Among these clones ST258 has been reported as a hybrid clone that was created by a large recombination event between ST11 and ST442 ([@B35]).

International high-risk *K. pneumoniae* ST11 has been frequently detected worldwide as a successful pathogen being associated with important co-resistance and virulence factors ([@B13]; [@B1]). However, in recent years, new drug-resistant lineages have emerged internationally and among them, KPC-producing *K. pneumoniae* ST307 has been recognized in the United States which was initially associated with production of CTX-M-15 ([@B12]). Later on, this clone has been reported in several countries including Italy, United Kingdom, Columbia, Pakistan, Morocco, Korea, Tunisia, China, Serbia ([@B24]; [@B21]; [@B22]; [@B40]; [@B39]; [@B33]; [@B38]; [@B50]; [@B52]).

Recent studies related to dissemination and antibiotic resistance of *K. pneumoniae* clones clearly showed that "fitness cost advantage" associated with high-level resistance to fluoroquinolones contributed to emergence of international high-risk *K. pneumoniae* clones. In hospital settings where fluoroquinolones are extensively used, international clones are selected out, allowing dominance over other clones ([@B47]; [@B18]; [@B19]). This capacity will provide these clones increased opportunities to spread as well as allow time to acquire antimicrobial drug resistance determinants from other bacteria ([@B35]). Whole-genome sequence analysis contributes to detect markers of pathogens, therefore in our study the aim was to investigate high-level fluoroquinolone resistance in *K. pneumoniae* high-risk clone ST11 and currently emerging ST307.

Materials and Methods {#s1}
=====================

Bacterial Strains
-----------------

In our preliminary examination, a total of 54 *Klebsiella* strains (53 *K. pneumoniae* and a single *K. oxytoca*) isolated from bloodstream infections of patients treated at intensive care units of Semmelweis University between 2010 and 2014 were collected. Species identification was done by MALDI-TOF/MS (Bruker Daltonics, Bremen, Germany). Minimum inhibitory concentration determination was performed by microdilution method based on EUCAST recommendation. ^[1](#fn01){ref-type="fn"}^ All *Klebsiella* strains were resistant to third-generation cephalosporins and showed reduced susceptibility or resistance to fluoroquinolones. All strains were tested for presence of PMQR genes and all of them were ESBL producers by phenotypic test. In this study, selection of strains was done based on the following criteria: (1) presence of *qnr* gene and non-wild type fluoroquinolone MIC values: Kox37 (isolated in 2010); (2) presence of *qnr* gene and high fluoroquinolone MIC values: Kpn33 (isolated in 2010), Kpn47 (isolated in 2014), Kpn125 (isolated in 2013); (3) multiple PMQR gene carriage together with high fluoroquinolone MIC values: Kpn115 (isolated in 2013) ([@B16]).

Multilocus Sequence Typing (MLST)
---------------------------------

Genotype of each strain was determined by MLST. The sequences of seven housekeeping genes namely, *gapA, infB, mdh, pgi, phoE, rpoB*, and *tonB* were amplified and directly sequenced. Alleles and sequence types were assigned by using the MLST database^[2](#fn02){ref-type="fn"}^ ([@B15]). The distance based relationship between the strains was investigated by BacWGST ([@B46]) using both the whole-genome MLST and SNP (sequenced based) strategies. Multiple genome analysis was carried out using all the draft genomes of this study and the *HS11286_CP003200_ST11* as a reference genome ([Figure 1](#F1){ref-type="fig"}).
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Pulsed Field Gel Electrophoresis (PFGE) Typing
----------------------------------------------

Clonal relatedness of the four *K. pneumoniae* strains was analyzed by PFGE according to CDC (2000) protocol. Prepared genomic DNA of each strain was digested by *Xba*I restriction endonuclease (Fermentas, ABI, Germany), and DNA fragments were separated in a PFGE CHEF-DR II system (Bio-Rad Laboratories, Hercules, CA, United States). Banding patterns were analyzed by Fingerprinting II Informatix Software (Bio-Rad). *Salmonella enterica* serotype Braenderup H9812 was used as a size marker ([@B27]).

Whole-Genome Sequencing (WGS)
-----------------------------

DNA of each strain was extracted by UltraClean Microbial DNA Isolation Kit (Qiagen GmbH, Hilden, Germany). Libraries were prepared using SureSelect QXT Library Prep Kit (Agilent Technologies, Santa Clara, United States). Sequencing was performed on an Illumina MiSeq system using the MiSeq reagent kit v2 generating 250-bp paired-end reads. Trimmomatic ([@B7]) was used for preprocessing the WGS data. If the average quality score was below 20 in a sliding window of 4 the adapter sequences and the leading and trailing bases were removed as well as the first 18 bases. Only the reads longer than 50 nucleotides were used for subsequent analysis. *De novo* genome assembly was performed with SPAdes Genome Assembler 3.13.0 ([@B3]). Each assembled genome was accepted for further analysis if it met all of the following quality criteria: (i) average coverage \> 30 times, (ii) N50 \> 15,000 bases, (iii) maximum contig length \> 50,000 bases, and (iv) assembled genome size between 5,000,000 and 6,500,000 bases. Assembled genomes were uploaded to the online bioinformatics tools ResFinder ([@B56]), PlasmidFinder ([@B11]) (Center for Genomic Epidemiology, Technical University of Denmark, Lyngby, Denmark) to analyse resistome and plasmid replicon types of the isolates.

Quantitative PCR (qPCR)
-----------------------

Total RNA of tested strains was isolated by RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. The qPCR was carried out in a Step One Real-Time PCR System (Applied BioSystems, Thermo Fisher Scientific). Separate expression of *qnrA1, qnrB1 qnrB4*, *oqxA*, and *oqxB* genes were investigated whereas chromosomal *rpoB* was chosen as housekeeping gene. Set of primers and 6-FAM or VIC labeled probes were designed by Primer Express 3.0 software. All oligonucleotide primers and probes for qPCR are listed in [Table 1](#T1){ref-type="table"}. Each RNA sample was tested in triplicate. The qPCR was applied in default setting 60°C 30 s; 50°C 5 min; 95°C 10 min; 40 cycles of \[95°C 15 s and 60°C 1 min\] 60°C 30 s. The C~T~ values of genes of interest were normalized (ΔC~T~) to the C~T~ values of housekeeping gene *rpoB* and the relative expression of each gene of interest was calculated as 2^−ΔC^~T\ =~ C~T~ ~(geneofinterest)~ -- C~T~ ~(rpoB).~

###### 

Primers used for qPCR (F, forward; R, reverse; P, probe).

  Gene        Primer sequence
  ----------- -------------------------------
  *qnrA1*-F   5′-TTGAGTGACAGCCGTTTTCG-3′
  *qnrA1*-R   5′-GCAGCTGACAGTGGCTGAAG-3′
  *qnrA1*-P   6-FAM-CTGCCGCTTTTATC-MGB
  *qnrB1*-F   5′-GTGCGCTGGGCATTGAA-3′
  *qnrB1*-R   5′-CGGAAATCTGCGCCTTGT-3′
  *qnrB1-*P   6-FAM-TTCGCCACTGCCGC-MGB
  *qnrB4*-F   5′-TGCGCTGGGAATCGAAA-3′
  *qnrB4*-R   5′-CGCGAAAATCTGACCCTTGT-3′
  *qnrB4*-P   6-FAM-TCGCCACTGCCGGG-MGB
  *oqxA*-F    5′-GTCGACGGCTTACAAAAAGTGTT-3′
  *oqxA*-R    5′-GCAACGGTTTTGGCGTTAA-3′
  *oqxA*-P    6-FAM-ATGCCGGGTATGCC-MGB
  *oqxB*-F    5′-CTGGATTTTCCGTCCGTTTAAC-3′
  *oqxB*-R    5′-TTGCCTACCAGTCCCTGATAGC-3′
  *oqxB*-P    6-FAM-CTGCGCAGCTCGAA-MGB
  *rpoB*-F    5′-GTCGCGGCTGAACAAGCT-3′
  *rpoB*-R    5′-AACGGCCACTTCGTAGAAGATC-3′
  *rpoB*-P    VIC-CTACGGCAGGTAACC-MGB

Results
=======

In our study, four *K. pneumoniae* and a single *K. oxytoca* were investigated by MLST and PFGE. Three different STs were identified, including ST11 (Kpn33, Kpn115, Kpn125), ST307 (Kpn47), and ST52 (Kox37).

Pulsed-field gel electrophoresis analysis detected three pulsotypes (PT) among *K. pneumoniae* strains, namely, KP053, S and KP197. Two isolates belonged to KP053 (Kpn33 and Kpn125) and one was detected as S PT (Kpn115). These strains belonged to the ST11 international high-risk clone. By contrast, Kpn47 was classified as KP197 PT ([Figure 2](#F2){ref-type="fig"}).
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The initial assembled draft genome sequences were 5611026 bp (Kpn33); 6370417 bp (Kox37); 5451744 bp, (Kpn47); 5450412 bp (Kpn115), and 5593358 bp (Kpn125). Seventeen antibiotic resistance genes were found in two ST11 *K. pneumoniae* strains (Kpn33 and Kpn125), twelve were in the third ST11 strain (Kpn115), sixteen resistant genes were in ST307 strain (Kpn47) and ten resistance genes were detected in Kox37. Sequence analysis revealed that the isolates harbored different β-lactamase genes, including *bla*~DHA--1~*, bla*~OXA--1~*, bla*~OXA--2~*, bla*~OXA--9~*, bla*~HV--11~*, bla*~HV--28~, and *bla*~TEM--1A~, *bla*~TEM--1B~*, bla*~OXY--1--3~*, bla*~TLA--1~; and all *K. pneumoniae* strains carried *bla*~CTX--M--15~. Among aminoglycoside resistance genes all isolates were positive for *aac(3)-IIa*. Only Kpn47 carried a tetracycline resistance (*tetA*) gene. Except for Kox37, all strains were identified positive for *fosA* gene nevertheless, *sul1* or *sul2* and trimethoprim resistance (*dfrA12, dfrA14, dfrA29*) genes were detected in four strains. PMQR genes were found in each tested strain namely, in Kpn33 *qnrB4*, in Kox37 *qnrA1*, in Kpn47 *qnrB1*, in Kpn125 *qnrB4.* All *K. pneumoniae* strains harbored *oqxAB* efflux pump and *aac(6*′*)-Ib-cr*, but one of the ST11 strains (Kpn115) carried no *qnr* gene. Presence of phenicol resistance gene (*catA1* or *catB3*) was observed in all strains. Chromosomal mutations conferring fluoroquinolone resistance in *K. pneumoniae* strains were also detected, Ser83Phe and Asp87Ala substitutions were in DNA gyrase subunit A of Kpn115 (ST11), but all other *K. pneumoniae* strains had only Ser83Ile in gyrase while on the other hand all *K. pneumoniae* had a Ser80Ile substitution in DNA topoisomerase IV. Based on the sequencing data, IncFIB, IncFII, and IncR replicons were uniformly present in all ST11 strains. In the case of ST307 IncFIB, IncL/M, IncHI1B were detected. The detected resistance genes and plasmid replicons are listed in [Table 2](#T2){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}.

###### 

Distribution of the different resistance genes and plasmid replicons of tested strains.

  ------------------------------
  ![](fmicb-10-00157-i001.jpg)
  ------------------------------

![Level of *qnrB4* (Kpn33 and Kpn125), *qnrA1* (Kox37), and *qnrB1, oqxA*, and *oqxB* relative gene expression. QRDRs: quinolone resistance determining regions. All MIC values are in mg/L.](fmicb-10-00157-g003){#F3}

Among *qnr* genes, *qnrB4* of two ST11 strains (Kpn33 and Kpn125) showed 9.74 and 3.55 fold expression, respectively. Interestingly, Kpn33 (ST11) was characterized approximately 3-fold higher expression, compared to the genetically similar Kpn125 (ST11). The lowest expression level (1.64) among *qnr* genes was detected in *K. oxytoca*, that exhibited reduced susceptibility to ciprofloxacin. In the case of *qnrB1* in Kpn47 (ST307), it showed 2.39 fold expression.

Expression of *oqxA* ranged between 1.47 and 3.92 and that of *oqxB* from 3.09 to 8.53. The highest *oqxA* and *oqxB* expressions were observed in Kpn33 (ST11) and Kpn47 (ST307). These were followed by Kpn125 (ST11) and Kpn115 (ST11). Interestingly, Kpn115 a strain of ST11 high-risk clone carried no *qnr* gene moreover, it showed the lowest *oqxAB* expression. It is conspicuous that in every *K. pneumoniae* strain the *oqxB* is expressed 2--3 fold higher than *oqxA*.

Discussion
==========

International high-risk *K. pneumoniae* ST11 clone has been frequently detected worldwide as a successful pathogen being associated with important virulence ([@B13]; [@B1]), and resistance determinants including VIM, NDM and KPC-production ([@B53]; [@B32]; [@B42]; [@B54]; [@B8]). In our study, all strains of ST11 international high-risk clone carried *bla*~SCTX--M--15~ ESBL that correlates well with earlier studies as the most common global ESBLs are the CTX-M type beta-lactamases in Enterobacterales ([@B37]). Recently, in a Bulgarian study among 82 ESBL-producing *K. pneumoniae* and four *K. oxytoca* CTX-M-15 (87%) was predominant ([@B34]). *K. pneumoniae* ST11 has been already reported in Hungary, as a widely disseminated clone in all over the country ([@B13]). In Poland, an inter-regional outbreak was reported that was dominated by NDM-1 and CTX-M-15 coproducing *K. pneumoniae* ST11 clone ([@B4]). A high prevalence (30.2%) of CTX-M-15-producing *K. pneumoniae* was detected in raw bovine milk too. This finding highlights the spread of CTX-M-15-producing *K. pneumoniae* also in the food chain ([@B14]).

In recent years, new drug-resistant international lineages have emerged, among them, KPC-producing *K. pneumoniae* ST307 has been recognized in several countries ([@B12]; [@B50]). To the best of our knowledge, our study is the first description of ST307 in Hungary that is has been reported as a potential high-risk clone. High similarity has been found in our ST307 isolate compared to that of detected by [@B50].

Three pulsotypes were identified among the investigated *K. pneumoniae* strains: KP053, S PT, and KP197. Two ST11 isolates belonged to KP053 (Kpn33 and Kpn125) and the third ST11 was detected as S PT (Kpn115) that was earlier reported in Hungary ([@B13]). In a Hungarian study, PFGE typing revealed 12 pulsotypes; of these, KP053 (262/312) and KP070 (38/312) belonged to sequence type ST11 ([@B30]); these data also prove the spread of KP053/ST11 clone in our country. *K. pneumoniae* ST307 (Kpn47) was classified as KP197 pulsotype, however, this type was not registered until 2014 by the National Public Health Institute. Since 2015, altogether 30 strains have been identified with this pulsotype in Hungary (unpublished data).

In this study, mutations in gyrase and topoisomerase coding genes and various PMQRs were detected in *K. pneumoniae* and *K. oxytoca*. Of the detected PMQRs in this study *oqxAB* was present in all *K. pneumoniae* clinical isolates but not in *K. oxytoca*. This result can be explained by the fact that the *oqxAB* is a chromosomally-encoded gene in *K. pneumoniae* ([@B55]). The *qnrB* genes were observed in *K. pneumoniae* ST11 correlating with the international data ([@B25]; [@B28]). However, this is the first report of the *qnr* gene in *K. oxytoca* ST52. Regarding plasmid replicon types, the most common replicon was IncFIB, that was present in all ST11, ST52, and ST307, which confirms earlier studies ([@B2]).

Acquisition of *qnr* determinants can have multiple advantages. In the case of *K. oxytoca*, the presence and expression of *qnrA1* caused reduced susceptibility to quinolones. Levofloxacin and moxifloxacin MIC values of *K. pneumoniae* ST11 and ST307 clones correlated with *qnr* and *oqxAB* expression levels ([Figure 3](#F3){ref-type="fig"}).

Further beneficial effect of Qnr proteins can be explained by the toxin-antitoxin effect. Qnr proteins are considered antitoxins, that protect gyrase and topoisomerase IV enzymes from naturally occuring toxins. This theory was described by [@B17] and it can be valid also in internationally disseminated high-risk clones ([@B17]). During development of fluoroquinolone resistance PMQR determinants play a role in reduced susceptibility, and they maintain low-level fluoroquinolone resistance ([@B20]). Later, by chromosomal mutations in QRDRs high-level fluoroquinolone resistance develops, but PMQR expression is maintained thus, indicating further role of PMQRs such as protection of gyrase and topoisomerase IV enzymes ([@B48],[@B49]; [@B43]).

It has been also established that the development of fluoroquinolone resistance is diverse among different clones and in the case of international high-risk *K. pneumoniae* clones the fluoroquinolone resistant strains retain fitness that facilitates their dissemination in hospital environment ([@B18]). Moreover, Redgrave et al. indicated that fluoroquinolone resistance played a key role in evolutionary success of *K. pneumoniae* clones ([@B43]).

Emergence and possible dissemination of *K. pneumoniae* ST307 in hospital settings raises also public health concerns, therefore continous monitoring of high-risk and potential high-risk clones is necessary.

Repository Data
===============

Assembled genomes of all investigated strains were deposited in NCBI Genbank under the following accession numbers. Raw sequence data of each strain in this study was submitted to Sequence Read Archive (SRA)

1.  Kpn 33: Bioproject: [PRJNA511518](PRJNA511518), Biosample [SAMN10639440](SAMN10639440)

2.  Kox37: Bioproject [PRJNA511522](PRJNA511522), Biosample: [SAMN106 39457](SAMN10639457)

3.  Kpn47: Bioproject: [PRJNA511523](PRJNA511523), Biosample: [SAMN10639726](SAMN10639726)

4.  Kpn115 Bioproject: [PRJNA511524](PRJNA511524), BioSamples [SAMN10639736](SAMN10639736)

5.  Kpn125: Bioproject: [PRJNA511525](PRJNA511525), BioSamples [SAMN10639737](SAMN10639737).
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